Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2021 Jun 29;11(1):13545.
doi: 10.1038/s41598-021-92625-x.

Comparison of the effectiveness of Martin's equation, Friedewald's equation, and a Novel equation in low-density lipoprotein cholesterol estimation

Affiliations
Clinical Trial

Comparison of the effectiveness of Martin's equation, Friedewald's equation, and a Novel equation in low-density lipoprotein cholesterol estimation

Youhyun Song et al. Sci Rep. .

Abstract

Low-density-lipoprotein cholesterol (LDL-C) is the main target in atherosclerotic cardiovascular disease (ASCVD). We aimed to validate and compare a new LDL-C estimation equation with other well-known equations. 177,111 samples were analysed from two contemporary population-based cohorts comprising asymptomatic Korean adults who underwent medical examinations. Performances of the Friedewald (FLDL), Martin (MLDL), and Sampson (SLDL) equations in estimating direct LDL-C by homogenous assay were assessed by measures of concordance (R2, RMSE, and mean absolute difference). Analyses were performed according to various triglyceride (TG) and/or LDL-C strata. Secondary analyses were conducted within dyslipidaemia populations of each database. MLDL was superior or at least similar to other equations regardless of TG/LDL-C, in both the general and dyslipidaemia populations (RMSE = 11.45/9.20 mg/dL; R2 = 0.88/0.91; vs FLDL: RMSE = 13.66/10.42 mg/dL; R2 = 0.82/0.89; vs SLDL: RMSE = 12.36/9.39 mg/dL; R2 = 0.85/0.91, per Gangnam Severance Hospital Check-up/Korea Initiatives on Coronary Artery Calcification data). MLDL had a slight advantage over SLDL with the lowest MADs across the full spectrum of TG levels, whether divided into severe hyper/non-hyper to moderate hypertriglyceridaemia samples or stratified by 100-mg/dL TG intervals, even up to TG values of 500-600 mg/dL. MLDL may be a readily adoptable and cost-effective alternative to direct LDL-C measurement, irrespective of dyslipidaemia status. In populations with relatively high prevalence of mild-to-moderate hypertriglyceridaemia, Martin's equation may be optimal for LDL-C and ASCVD risk estimation.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Flowchart of study design. N number; HDL-C high-density lipoprotein cholesterol; Non-HDL-C non-high-density lipoprotein cholesterol; TC total cholesterol; LDL-C low-density lipoprotein cholesterol; dLDL direct LDL-C; TG triglyceride; GSHC Gangnam Severance Hospital Check-up; KOICA Korea Initiatives on Coronary Artery Calcification.
Figure 2
Figure 2
Scatter plots showing the correlation of direct LDL-C values with estimated LDL-C values using the Friedewald, Martin/Hopkins, and Sampson equations. RMSE root mean square error; GSHC Gangnam Severance Hospital Check-up; KOICA Korea Initiatives on Coronary Artery Calcification; LDL-C low-density lipoprotein cholesterol; dLDL direct LDL-C; TG triglyceride.
Figure 3
Figure 3
Residual error plots for LDL-C by different equations. (a) Severe hyperTG/ TG < 400 mg/dL; (b) High/Low LDL-C. MAD mean absolute difference; RMSE root mean square error; LDL-C low-density lipoprotein cholesterol; dLDL direct LDL-C; TG triglyceride; GSHC Gangnam Severance Hospital Check-up; KOICA Korea Initiatives on Coronary Artery Calcification.
Figure 4
Figure 4
Comparison of the mean absolute difference scores between direct LDL-C and different estimated LDL-C values for various TG and LDL-C levels. TG triglyceride; LDL-C low-density lipoprotein cholesterol; GSHC Gangnam Severance Hospital Check-up; KOICA Korea Initiatives on Coronary Artery Calcification.

Similar articles

Cited by

References

    1. Cholesterol Treatment Trialists, C. et al. Efficacy and safety of more intensive lowering of LDL cholesterol: A meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet. 2010;376:1670–1681. doi: 10.1016/S0140-6736(10)61350-5. - DOI - PMC - PubMed
    1. Grundy SM, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: A report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. J. Am. Coll. Cardiol. 2019;73:e285–e350. doi: 10.1016/j.jacc.2018.11.003. - DOI - PubMed
    1. Arnett DK, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: Executive summary: A report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. J. Am. Coll. Cardiol. 2019;74:1376–1414. doi: 10.1016/j.jacc.2019.03.009. - DOI - PMC - PubMed
    1. Mach F, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. Eur. Heart J. 2020;41:111–188. doi: 10.1093/eurheartj/ehz455. - DOI - PubMed
    1. Sampson M, et al. A new equation for calculation of low-density lipoprotein cholesterol in patients with normolipidemia and/or hypertriglyceridemia. JAMA Cardiol. 2020 doi: 10.1001/jamacardio.2020.0013. - DOI - PMC - PubMed

Publication types